ALSO NOTED: Former BMJ head says medical journals 'too close' to drug companies; Growing pains for Sutter Health; and much mo

> The former head of the British Medical Journal says medical journals are "too close to drug companies." Story

> After an ambitious expansion in the mid-1990s, Sutter Health has gone on to become a major player. But things haven't worked out quite the way managers had hoped. Story

> Israeli generic maker Teva wins FDA approval for its version of Abbott Laboratories' cholesterol drug Tricor. The case now moves to the courts. Story

> The NIH has chosen InnerWireless for wireless networking applications in its new clinical research center. Release

> Increasingly, pharma companies are choosing to hold clinical trials overseas in countries where costs are lower and regulatory oversight is often non-existent. Story

> A look at the marketing of the heart drug Natrecor. Story

> Retailer Pathmark announced it will use NDCHealth's electronic claims processing system at its pharmacies. Story

> Was Aetna's acquisition of ActiveHealth a good move? Story

> In India, surgeons at Wockhardt Heart hospital perform AWCB (Awake Coronary Bypass Surgery) while patients remain conscious. The ambitious goal: to cut hospital stays for bypass patients down to one day. Story

> A tiny camera contained in swallowable capsule turns out to be very good at finding polyps, a study finds. Story

> The Kaiser Family Foundation presents a webcast of "Medicare Basics A to D." Story

And Finally... A gruesome tour of medical history at the National Museum of Health and Medicine. Story

Post a comment